Johnson & Johnson Receives FDA Approval For STELARA To Treat Moderately To Severely Active Crohn's Disease

Benzinga Newsdesk www.benzinga.com Neutral 93.1%

Neg 0% Neu 93.1% Pos 0%

https://www.jnj.com/media-center/press-releases/stelara-pediatric-crohns-disease-fda-approval-j-j-statement

Comments

No comments yet. Be the first!